What your cardiologist (should have) learned last month

by Carolyn Thomas  @HeartSisters

After a bunch of top cardiologists got together in San Francisco recently for the annual American College of Cardiology scientific meetings, Debra Sherman and her team did a fine job summing up highlights for Reuters.*  One of their first take-home messages: some cardiologists believe that drug prescribing has gotten out of hand.  Continue reading “What your cardiologist (should have) learned last month”

Women at greater risk for side effects when taking statin drugs for cholesterol

by Carolyn Thomas  @HeartSisters

Statins are the largest selling class of prescription drugs on earth, and account for over 40% of all heart  medications. Lipitor, for example, at over $26 billion in global sales, was the world’s biggest selling drug, manufactured by the world’s biggest drug company, Pfizer.

Because of their effectiveness in managing cholesterol levels, statins are often prescribed to lower total cholesterol in the belief that lower numbers will mean fewer heart attacks. Most people who are prescribed statins are healthy people who don’t have heart disease but who simply have high cholesterol. They will take these drugs for the rest of their lives, making statins a dream drug for the pharmaceutical companies that make them. Continue reading “Women at greater risk for side effects when taking statin drugs for cholesterol”